William Goeckeler

1.1k total citations
20 papers, 913 citations indexed

About

William Goeckeler is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, William Goeckeler has authored 20 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Radiology, Nuclear Medicine and Imaging, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in William Goeckeler's work include Radiopharmaceutical Chemistry and Applications (17 papers), Prostate Cancer Treatment and Research (7 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). William Goeckeler is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (17 papers), Prostate Cancer Treatment and Research (7 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). William Goeckeler collaborates with scholars based in United States, Germany and Australia. William Goeckeler's co-authors include Wynn A. Volkert, Gary J. Ehrhardt, A.R. Ketring, W. A. Volkert, Daniela A. Wilson, Richard A. Holmes, William C. Olson, Gerald P. Donovan, Diane Eggensperger and Kathleen Siler and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

William Goeckeler

20 papers receiving 864 citations

Peers

William Goeckeler
Darpan N. Pandya United States
François Guérard France
M W Brechbiel United States
Alejandro Amor‐Coarasa United States
Alexandra D. Varvarigou Greece
Diane S. Abou United States
S. Kasina United States
Jean‐François Gestin France
R. Molinet Germany
Kavitha Sunassee United Kingdom
Darpan N. Pandya United States
William Goeckeler
Citations per year, relative to William Goeckeler William Goeckeler (= 1×) peers Darpan N. Pandya

Countries citing papers authored by William Goeckeler

Since Specialization
Citations

This map shows the geographic impact of William Goeckeler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Goeckeler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Goeckeler more than expected).

Fields of papers citing papers by William Goeckeler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Goeckeler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Goeckeler. The network helps show where William Goeckeler may publish in the future.

Co-authorship network of co-authors of William Goeckeler

This figure shows the co-authorship network connecting the top 25 collaborators of William Goeckeler. A scholar is included among the top collaborators of William Goeckeler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Goeckeler. William Goeckeler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miyahira, Andrea K., Kenneth J. Pienta, Michael J. Morris, et al.. (2018). Meeting report from the Prostate Cancer Foundation PSMA‐directed radionuclide scientific working group. The Prostate. 78(11). 775–789. 32 indexed citations
2.
Sartor, Oliver, William Goeckeler, & Øyvind S. Bruland. (2011). Stromal targeted therapy in bone metastatic prostate cancer: promise delivered. Asian Journal of Andrology. 13(6). 783–784. 3 indexed citations
3.
Engstrom, Paul F., George D. Demetri, Phillip G. Febbo, et al.. (2011). NCCN Molecular Testing White Paper: Effectiveness, Efficiency, and Reimbursement. Journal of the National Comprehensive Cancer Network. 9(Suppl_6). S–1. 36 indexed citations
4.
Chakraborty, Mala, Elizabeth K. Wansley, Jorge A. Carrasquillo, et al.. (2008). The Use of Chelated Radionuclide (Samarium-153-Ethylenediaminetetramethylenephosphonate) to Modulate Phenotype of Tumor Cells and Enhance T Cell–Mediated Killing. Clinical Cancer Research. 14(13). 4241–4249. 59 indexed citations
5.
Tedesco, J. L., William Goeckeler, Dongwei Gao, et al.. (2007). Development and characterization of a novel 177Lu-MeO-DOTA-7E11 antibody construct (CYT-500) for the treatment and imaging of prostate adenocarcinoma. Cancer Research. 67. 4745–4745. 1 indexed citations
6.
Tedesco, J. L., et al.. (2006). Development of optimal Lu-177 labeled monoclonal antibody (7E11) constructs (CYT-500) for radioimmunotherapy of hormone refractory prostate cancer. Clinical Cancer Research. 12. 1 indexed citations
7.
Ma, Dangshe, Gerald P. Donovan, Peter D. Senter, et al.. (2006). Potent Antitumor Activity of an Auristatin-Conjugated, Fully Human Monoclonal Antibody to Prostate-Specific Membrane Antigen. Clinical Cancer Research. 12(8). 2591–2596. 105 indexed citations
8.
Swift, Regina A., et al.. (2006). Phase I study of bortezomib and 153Sm-lexidronam combination for refractory and relapsed multiple myeloma. Journal of Clinical Oncology. 24(18_suppl). 7614–7614. 4 indexed citations
9.
Tedesco, J. L., et al.. (2005). Development of optimal Lu-177 labeled monoclonal antibody (7E11) constructs for radioimmunotherapy of prostate cancer. Journal of Clinical Oncology. 23(16_suppl). 4765–4765. 1 indexed citations
10.
Ma, Donghui, Jason P. Gardner, Gerald P. Donovan, et al.. (2004). Fully human monoclonal antibodies to PSMA selectively target cytotoxins, radiotoxins and host immunity to prostate cancer. Journal of Clinical Oncology. 22(14_suppl). 2546–2546. 4 indexed citations
11.
Schlom, Jeffrey, Kathleen Siler, Diane E. Milenic, et al.. (1994). Biodistribution and preclinical radioimmunotherapy studies using radiolanthanide-labeled immunoconjugates. Cancer. 73(S3). 993–998. 30 indexed citations
12.
Goeckeler, William, et al.. (1993). Analysis of urine samples from metastatic bone cancer patients administered 153Sm-EDTMP. Nuclear Medicine and Biology. 20(5). 657–661. 9 indexed citations
13.
Schlom, Jeffrey, Kathleen Siler, Diane E. Milenic, et al.. (1991). Monoclonal antibody-based therapy of a human tumor xenograft with a 177lutetium-labeled immunoconjugate.. PubMed. 51(11). 2889–96. 95 indexed citations
14.
Volkert, Wynn A., William Goeckeler, Gary J. Ehrhardt, & A.R. Ketring. (1991). Therapeutic radionuclides: production and decay property considerations.. PubMed. 32(1). 174–85. 233 indexed citations
15.
Lattimer, Jimmy C., Wynn A. Volkert, Gary J. Ehrhardt, et al.. (1990). Clinical and clinicopathologic response of canine bone tumor patients to treatment with samarium-153-EDTMP.. PubMed. 31(8). 1316–25. 61 indexed citations
16.
Lattimer, Jimmy C., Jack T. Stapleton, Wynn A. Volkert, et al.. (1990). Clinical and clinicopathologic effects of samarium-153-EDTMP administered intravenously to normal beagle dogs.. PubMed. 31(5). 586–93. 25 indexed citations
17.
Goeckeler, William, et al.. (1987). Skeletal localization of samarium-153 chelates: potential therapeutic bone agents.. PubMed. 28(4). 495–504. 176 indexed citations
18.
Goeckeler, William, et al.. (1986). 153Sm radiotherapeutic bone agents. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 13(4). 479–482. 34 indexed citations
19.
Lattimer, Jimmy C., William Goeckeler, Jack H. Simon, et al.. (1986). Radioisotope radiotherapy of canine primary bone tumors with Samariijm-153 EDTMP. International Journal of Radiation Oncology*Biology*Physics. 12. 183–183. 1 indexed citations
20.
Ehrhardt, Gary J., et al.. (1983). A new Cd-115 leads to In-115m radionuclide generator.. PubMed. 24(4). 349–52. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Darpan N. Pandya Breakdown of academic impact, for papers by François Guérard Breakdown of academic impact, for papers by M W Brechbiel Breakdown of academic impact, for papers by Alejandro Amor‐Coarasa Breakdown of academic impact, for papers by Alexandra D. Varvarigou Breakdown of academic impact, for papers by Diane S. Abou Breakdown of academic impact, for papers by S. Kasina Breakdown of academic impact, for papers by Jean‐François Gestin Breakdown of academic impact, for papers by R. Molinet Breakdown of academic impact, for papers by Kavitha Sunassee
Rankless by CCL
2026